Prosecution Insights
Last updated: May 29, 2026

Jiangnan University

8 pending office actions • 5 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 57 patents granted in the last 365 days

Portfolio Summary

8
Total Pending OAs
4
Non-Final OAs
3
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
3
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (3)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
5
Medium (62%)
2
Easy (25%)
1
Unknown (12%)

Rejection Statute Mix

BucketCases
§103 only5 (62%)
§112 only2 (25%)
No statute on record1 (12%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

8
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GRASER, JENNIFER E 1 76.7% +23.8%
SKOKO III, JOHN JOSEPH 1 52.8% +58.4%
DEVI, SARVAMANGALA 1 65.4% +55.0%
ZEMAN, ROBERT A 1 54.0% +27.8%
MAHLUM, JONATHAN DAVIS 1 57.7% +6.9%
SWEENEY, MAURA ELIZABETH 1 2.2% -2.8%
MORGAN, BAILEY MICHELLE 1 57.1% +56.3%
EIX, EMILY FAY 1 52.2% +64.7%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17989846 METHOD FOR PREPARING EMULSION GEL-BASED FAT SUBSTITUTE WITH ADJUSTABLE PHASE CHANGE AND USE THEREOF SWEENEY, MAURA ELIZABETH 45d overdue

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17746130 THERMAL SWITCH SYSTEM AND APPLICATION THEREOF IN IMPROVING YIELD OF AMINO ACID EIX, EMILY FAY 145d overdue
17935466 BACILLUS SUBTILIS STRAIN, RECOMBINANT BACILLUS SUBTILIS STRAIN AND USE THEREOF MORGAN, BAILEY MICHELLE 77d overdue
18335275 Lactobacillus gasseri capable of alleviating and treating hyperuricemia DEVI, SARVAMANGALA 12d
18650203 Bifidobacterium animalis in enriching organic zinc to promote growth and reproductive development GRASER, JENNIFER E 14d
18337631 ANTIBODY CONJUGATE AND METHOD FOR ENHANCING IMMUNE EFFECT FUNCTION OF ANTIBODY MOLECULE SKOKO III, JOHN JOSEPH 14d
18191919 Bifidobacterium longum for Preventing and/or Treating Essential Hypertension ZEMAN, ROBERT A 63d

Top Art Units

Art UnitApps
1645 4
1643 1
1625 1
1791 1
1653 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18650203 Bifidobacterium animalis in enriching organic zinc to promote growth and reproductive development GRASER, JENNIFER E 1645 §103 Non-Final OA 14d Pending Apr 30, 2024
18337631 ANTIBODY CONJUGATE AND METHOD FOR ENHANCING IMMUNE EFFECT FUNCTION OF ANTIBODY MOLECULE SKOKO III, JOHN JOSEPH 1643 §103 Non-Final OA 14d Pending Jun 20, 2023
18335275 Lactobacillus gasseri capable of alleviating and treating hyperuricemia DEVI, SARVAMANGALA 1645 Final Rejection 12d Pending Jun 15, 2023
18191919 Bifidobacterium longum for Preventing and/or Treating Essential Hypertension ZEMAN, ROBERT A 1645 §112 Final Rejection 63d Pending Mar 29, 2023
17990976 Application of microbiota-derived plasmalogens to Treatment of Colon Cancer MAHLUM, JONATHAN DAVIS 1625 §103 Non-Final OA 16d overdue Pending Nov 21, 2022
17989846 METHOD FOR PREPARING EMULSION GEL-BASED FAT SUBSTITUTE WITH ADJUSTABLE PHASE CHANGE AND USE THEREOF SWEENEY, MAURA ELIZABETH 1791 §103 Final Rejection 45d overdue Pending Nov 18, 2022
17935466 BACILLUS SUBTILIS STRAIN, RECOMBINANT BACILLUS SUBTILIS STRAIN AND USE THEREOF MORGAN, BAILEY MICHELLE 1645 §112 Non-Final OA 77d overdue Pending Sep 26, 2022
17746130 THERMAL SWITCH SYSTEM AND APPLICATION THEREOF IN IMPROVING YIELD OF AMINO ACID EIX, EMILY FAY 1653 §103 Non-Final OA 145d overdue Pending May 17, 2022

Managing Jiangnan University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month